Jefferies is out with its report today on Aetna AET, maintaining Hold.
In a note to clients, Jefferies writes, "AET made two announcements yesterday: 1) CMS lifted marketing and
enrollment sanctions on MA and PDP; and 2) AET acquired Genworth's Medicare Supplement business. Both releases are positive, but the former was announced after the market closed (M&A deal was disclosed before the market opened) and should have more meaningful implications for investors."
Jefferies maintains a $50 PT on AET.
Shares of AET closed Monday at $42.75, down 0.26% from Friday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in